Viral Hepatitis: Diagnosis, Treatment and Management—2nd Edition
A special issue of Diseases (ISSN 2079-9721).
Deadline for manuscript submissions: 30 September 2026 | Viewed by 14
Special Issue Editors
Interests: infectious disease; liver diseases
Special Issues, Collections and Topics in MDPI journals
Interests: abdominal pain; bloating; bloody stool; celiac disease; Clostridium difficile colitis (C. diff); constipation; Crohn’s disease; diarrhea; dysphagia; gastroesophageal reflux disease (GERD); hepatitis C; inflammatory bowel disease (IBD); irritable bowel syndrome (IBS); liver diseases; nausea; pancreatitis; nutrition; vomiting; colon cancer screening
Special Issues, Collections and Topics in MDPI journals
Interests: colorectal cancer; colon polyps; esophageal cancer; celiac disease; crohn's disease; inflammatory bowel disease; lactose intolerance; chronic diarrhea; constipation; gastrointestinal reflux disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the second edition of the Special Issue “Viral Hepatitis: Diagnosis, Treatment and Management”, available at https://www.mdpi.com/journal/diseases/special_issues/LA151P824R.
We are pleased to invite you to contribute to our Special Issue entitled “Viral Hepatitis: Diagnosis, Treatment and Management”. Viral hepatitis is a main public health concern that can become chronic and eventually lead to end-stage liver disease. Viral hepatitis is also one of the leading indications for liver transplantation. Hepatitis can be classified into acute and chronic based on the duration of the inflammation in the liver. Depending on the etiology of hepatitis, the severity of acute hepatitis can range from mild and self-limiting to severe illness requiring liver transplantation.
Viral hepatitis is most frequently caused by the hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). These three viruses can lead to an acute disease with signs and symptoms of nausea, abdominal pain, fatigue, malaise, and jaundice. Other viruses known to cause hepatitis include the hepatitis D virus (HDV) and hepatitis E virus (HEV). Acute infection with HBV and HCV can lead to chronic infection. For HDV infection to occur, HBV infection must have occurred previously or concurrently. Chronic hepatitis may lead to the development of liver fibrosis, cirrhosis, hepatocellular carcinoma, and portal hypertension, corresponding to significant morbidity and mortality.
This Special Issue aims to reveal the current evidence for the diagnosis, treatment and management of acute and chronic viral hepatitis. It aims to discuss the challenges associated with screening, diagnosis, and referral of viral hepatitis, current and future treatment options, and areas of potential research interests.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Screening and diagnosis of viral hepatitis;
- Diagnosis and management of acute hepatitis (A, B, C, D, E);
- Diagnosis and management of chronic hepatitis (B, C, D);
- Prevention of reactivation of HBV infection;
- Management of coinfections (HBV/HCV, HBV-HIV, HCV/HIV);
- Management of chronic HBV and HCV infections in special patient groups;
- Management of cirrhosis, hepatocellular carcinoma, and portal hypertension.
I/We look forward to receiving your contributions.
Dr. Resat Ozaras
Dr. Veysel Tahan
Dr. Ebubekir Dağlılar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diseases is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral hepatitis
- acute hepatitides (A, B, C, D, E)
- chronic hepatitides (B, C, D)
- HBV infection
- HBV/HCV
- HBV-HIV
- HCV/HIV
- cirrhosis
- hepatocellular carcinoma
- portal hypertension
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
